Skip to main content
Contact Us
Subscriber Sign In
navigation
サイト内検索
What We Do
Commercial Intelligence
Products
Evaluate Pharma
Evaluate Omnium
Evaluate Medtech
Evaluate Epi
Japan Drug Forecasts
Europe Drug Forecasts
CDMO Intelligence
Pharma Consulting & Analytics
Pharma Consulting & Analytics
Data Feeds
Evaluate Vantage
News
Analysis
Policy & Pricing
Insights
Events
Medtech
Therapy Areas
Evaluate for Biotech
How We Can Help You
Pharma and Biotech
Financial Services
Management Consultancies
Service Providers
Customer Testimonials
Thought Leadership
Multimedia
Blog
About Us
Press Releases
Media Coverage
Executive Team
Vision & History
Contact Us
Sign Up for Evaluate Vantage
Talent
Subscriber Sign In
Search
Open configuration options
Search
Vantage
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
Breadcrumb
Home
Vantage
Pharmaceutical Companies
Sirtex Medical
Evaluate
July 03, 2019
Varian finally gets some beads as Boston does a swap
June 15, 2018
Snippet roundup: Panel says no to BTG and Sirtex says no to Varian
May 11, 2018
Snippet roundup: Pivotal fluffs from Faron and Fasenra
January 30, 2018
Varian goes internal with $1.6bn Sirtex deal
May 19, 2017
Snippet roundup: Bladder cancer nod for Keytruda and success for Syndax in melanoma
April 25, 2017
Sirtex trial miss means beads could stay as back-up
January 09, 2017
A quiet year for mid-size medtech
July 06, 2016
Smaller medtechs in charge of their own destiny
June 01, 2015
Asco – Sirtex spins surrogate hit but no chance for first-line use
March 17, 2015
Sirtex slips on its beads after trial miss
January 15, 2015
Mid-cap medtech shares rise in 2014 on deals and the possibility of more
Load More
Latest Reports
July 27, 2023
H1 Round Up: The haves and the have-nots
July 21, 2023
ADA/EASL eBook
Editor's Picks
July 03, 2023
Astrazeneca and Daiichi’s big reveal disappoints
July 13, 2023
Pharma finds a way to gain weight
July 03, 2023
Protagonist investors flake as psoriasis pill disappoints
June 29, 2023
Approaching datasets for big pharma
June 27, 2023
Nkarta goes back to basics